Can starting levothyroxine (thyroid hormone replacement) lower free testosterone levels in a woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Starting Thyroid Medication and Testosterone Levels in Women

Starting levothyroxine in women with hypothyroidism typically decreases testosterone levels, not increases them. This is the opposite of what the question asks, but it's the clinically important relationship you need to understand.

The Actual Relationship: Hypothyroidism Raises Testosterone

Here's what happens in real clinical practice:

Untreated hypothyroidism is associated with elevated testosterone levels in women, particularly free testosterone. When you start levothyroxine and restore euthyroidism, testosterone levels normalize (decrease) 1. This was demonstrated in a prospective study where hypothyroid women had significantly higher total testosterone levels, and thyroid hormone replacement achieved significant reductions in both total and free testosterone 1.

The Mechanism

The key mechanism involves sex hormone-binding globulin (SHBG):

  • Hypothyroidism decreases SHBG production 2
  • Lower SHBG means more free (bioactive) testosterone circulating
  • When you treat with levothyroxine, SHBG levels normalize
  • This binds more testosterone, reducing free testosterone levels

One study found that women on L-T4 therapy had significantly lower SHBG levels compared to controls (p < 0.001), with correspondingly altered testosterone dynamics 2. Another study in postmenopausal women with Hashimoto's thyroiditis confirmed that hypothyroid patients had significantly higher free testosterone (7.89 ± 3.55 pmol/L) compared to euthyroid patients (7.19 ± 5.65 pmol/L, p < 0.05) 3.

Clinical Algorithm

When starting levothyroxine in a woman:

  1. Expect testosterone to decrease as thyroid function normalizes

  2. Monitor for resolution of hyperandrogenic symptoms (if present):

    • Hirsutism may improve
    • Acne may resolve
    • Polycystic ovary appearance may reverse 1
  3. Timing of hormonal changes:

    • TSH normalizes within 4-8 weeks 4
    • Androgen levels normalize within 2-3 months of achieving euthyroidism 1
    • SHBG recovery may lag behind, taking up to 6 months 5

Important Caveats

One older study from 1988 reported hirsutism as a side effect of L-T4 treatment 2, but this appears to be an outlier finding not replicated in more recent, higher-quality research. The preponderance of evidence, including prospective studies, demonstrates the opposite effect—that levothyroxine treatment reduces testosterone levels in hypothyroid women 1, 3.

The FDA label for levothyroxine does not list testosterone changes as a recognized drug interaction or adverse effect 6. The drug interactions focus on absorption issues, protein binding alterations, and metabolic effects—but not sex hormone changes.

Bottom Line for Clinical Practice

If a woman develops elevated testosterone or hyperandrogenic symptoms after starting levothyroxine, look for alternative explanations:

  • Overtreatment causing hyperthyroidism (which can alter androgen metabolism differently)
  • Concurrent development of polycystic ovary syndrome
  • Adrenal pathology
  • Medication interactions affecting SHBG (estrogens, androgens, glucocorticoids) 6

The expected physiological response is testosterone normalization (decrease) when treating hypothyroidism, not an increase.

References

Guideline

clinical practice guidelines for hypothyroidism in adults: cosponsored by the american association of clinical endocrinologists and the american thyroid association.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2012

Research

Serum androgen levels in hyperthyroid women.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.